[1]
M.-C. S. Malinao, M. Kramer, C. Elchman, B. Rivera, S. Orlowicz, and H. Behr, “Analytical Comparison of Infliximab and Related Biosimilars”, Acta Pharm Hung, vol. 91, no. 3-4, p. 184, Nov. 2021.